Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shama Virani

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Head & Neck|February 17, 2016
Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinomaNghia Nguyen, Emily Bellile, Daffyd Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2016
Subtypes of HPV-Positive Head and Neck Cancers Are Associated with HPV Characteristics, Copy Number Alterations, PIK3CA Mutation, and Pathway SignaturesYanxiao Zhang, Lada A Koneva, Shama Virani, et al.
BMC Cancer|November 1, 2015
NDN and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomasShama Virani, Emily Bellile, Carol R Bradford, et al.
Head & Neck|May 10, 2026
Health System Factors in Head and Neck Cancer Diagnosis: A HEADSpAcE Consortium Qualitative Study in Glasgow and MontevideoGrant Creaney, Iván Lyra González, Mauricio Cuello, et al.
Nutrition and Cancer|March 14, 2019
Soy Isoflavone Supplementation Increases Long Interspersed Nucleotide Element-1 (LINE-1) Methylation in Head and Neck Squamous Cell CarcinomaLaura S Rozek, Shama Virani, Emily L Bellile, et al.
Plos One|January 30, 2013
Comprehensive analysis of DNA methylation in head and neck squamous cell carcinoma indicates differences by survival and clinicopathologic characteristicsJustin A Colacino, Dana C Dolinoy, Sonia A Duffy, et al.
Carcinogenesis|May 26, 2021
Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma researchShama Virani, Glauco Baiocchi, David Bowtell, et al.
Head & Neck|June 8, 2024
Development and external validation of a head and neck cancer risk prediction modelCraig D L Smith, Alex D McMahon, Donald M Lyall, et al.
Eclinicalmedicine|December 8, 2025
Regular use of pharmaceutical opioids and subsequent risk of cancer: a prospective cohort study and Mendelian randomization analysisMahdi Sheikh, Allison Domingues, Karine Alcala, et al.
Journal of the National Cancer Institute|June 13, 2025
Proteogenomic and observational evidence implicate ANGPTL4 as a potential therapeutic target for colorectal cancer preventionJames Yarmolinsky, Matthew A Lee, Evelyn Lau, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Head & Neck|February 17, 2016
Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinomaNghia Nguyen, Emily Bellile, Daffyd Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2016
Subtypes of HPV-Positive Head and Neck Cancers Are Associated with HPV Characteristics, Copy Number Alterations, PIK3CA Mutation, and Pathway SignaturesYanxiao Zhang, Lada A Koneva, Shama Virani, et al.
BMC Cancer|November 1, 2015
NDN and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomasShama Virani, Emily Bellile, Carol R Bradford, et al.
Head & Neck|May 10, 2026
Health System Factors in Head and Neck Cancer Diagnosis: A HEADSpAcE Consortium Qualitative Study in Glasgow and MontevideoGrant Creaney, Iván Lyra González, Mauricio Cuello, et al.
Nutrition and Cancer|March 14, 2019
Soy Isoflavone Supplementation Increases Long Interspersed Nucleotide Element-1 (LINE-1) Methylation in Head and Neck Squamous Cell CarcinomaLaura S Rozek, Shama Virani, Emily L Bellile, et al.
Plos One|January 30, 2013
Comprehensive analysis of DNA methylation in head and neck squamous cell carcinoma indicates differences by survival and clinicopathologic characteristicsJustin A Colacino, Dana C Dolinoy, Sonia A Duffy, et al.
Carcinogenesis|May 26, 2021
Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma researchShama Virani, Glauco Baiocchi, David Bowtell, et al.
Head & Neck|June 8, 2024
Development and external validation of a head and neck cancer risk prediction modelCraig D L Smith, Alex D McMahon, Donald M Lyall, et al.
Eclinicalmedicine|December 8, 2025
Regular use of pharmaceutical opioids and subsequent risk of cancer: a prospective cohort study and Mendelian randomization analysisMahdi Sheikh, Allison Domingues, Karine Alcala, et al.
Journal of the National Cancer Institute|June 13, 2025
Proteogenomic and observational evidence implicate ANGPTL4 as a potential therapeutic target for colorectal cancer preventionJames Yarmolinsky, Matthew A Lee, Evelyn Lau, et al.
Pageof 5